Vitruvian Partners’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.2M Hold
1,250,000
43.09% 1
2025
Q4
$58.1M Hold
1,250,000
41.73% 1
2025
Q3
$61.4M Hold
1,250,000
42.55% 1
2025
Q2
$64.7M Buy
+1,250,000
New +$50.5M 39.39% 1

Other funds holding HNGE

Vitruvian Partners's HNGE Position: Q1 2026 in Review

Vitruvian Partners held its Hinge Health (HNGE) position steady in Q1 2026 at 1,250,000 shares worth $48.2M. The position accounts for 43.09% of the portfolio, ranked #1.

Vitruvian Partners first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $64.7M in Q2 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Vitruvian Partners held 1,250,000 shares of Hinge Health worth $48.2M as of Q1 2026.
  • Vitruvian Partners left its Hinge Health share count unchanged in Q1 2026.
  • Hinge Health made up 43.09% of Vitruvian Partners's portfolio in Q1 2026, its #1 holding.
  • Vitruvian Partners first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • Vitruvian Partners's Hinge Health position peaked at $64.7M in Q2 2025.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Vitruvian Partners's 13F filing for Q1 2026, filed 11 May 2026.